My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Research-backed Investing ...in less than a minute.
BSE: 524711 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Vista Pharmaceuticals Ltd a good quality company?
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vista Pharmaceuticals Ltd is a below average quality company.
2. Is Vista Pharmaceuticals Ltd undervalued or overvalued?
The key valuation ratios of Vista Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is Vista Pharmaceuticals Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vista Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | 1% | 5.3% | 14.5% | 8.4% | 7.9% | 8.8% | 2.6% | -5.9% | -2.1% | -0.4% | - | ||
| Value Creation Index ⓘ | -0.9 | -0.6 | 0.0 | -0.4 | -0.4 | -0.4 | -0.8 | -1.4 | -1.2 | -1.0 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 7.5 | 8.3 | 13.8 | 15.4 | 24.2 | 28.9 | 31.1 | 22.8 | 1.3 | 0.4 | 0 | ||
| YoY Gr. Rt. % | - | 11.1% | 65.7% | 11.9% | 57.2% | 19.6% | 7.4% | -26.8% | -94.4% | -69.3% | - | ||
| Adj EPS ⓘ | 0 | 0.1 | 0.1 | 0.4 | 0.5 | 0.7 | 0 | -1.3 | -0.6 | -0.2 | 0.1 | ||
| YoY Gr. Rt. % | - | 500% | 83.3% | 218.2% | 34.3% | 48.9% | -100% | NA | NA | NA | - | ||
| BVPS (₹) ⓘ | 5.8 | 6.1 | 4.2 | 4.5 | 6.3 | 9 | 11 | 9.8 | 8.9 | 9.6 | 9.1 | ||
| Adj Net Profit ⓘ | 0.1 | 0.5 | 1.4 | 0.9 | 1.3 | 2 | 0 | -3.8 | -2 | -0.8 | 0 | ||
| Cash Flow from Ops. ⓘ | 0.2 | -0.1 | -3.5 | -2.5 | 2.6 | -4.6 | 3.3 | 0.8 | -6.8 | -1 | - | ||
| Debt/CF from Ops. ⓘ | 0 | 0 | -1.1 | -3.2 | 4.4 | -2.4 | 3.4 | 19.3 | -1.6 | -12.6 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | -28% | -56.2% | -76.8% | -69.3% | ||||||||
| Adj EPS ⓘ | -241.7% | -186.7% | NA | NA | ||||||||
| BVPS ⓘ | 5.9 | 9.1 | -4.2 | 8 | ||||||||
| Share Price | 8.1% | -25.6% | 18.4% | -11.1% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | 0.9 | 5.3 | 14.5 | 8 | 9 | 8.4 | 0 | -11.6 | -6.4 | -2.4 | 1 | |
| Op. Profit Mgn % ⓘ | 10.9 | 14.7 | 20.3 | 17.7 | 12.6 | 18.5 | 4 | -21.1 | -136.6 | -306.8 | 0 | |
| Net Profit Mgn % ⓘ | 1.1 | 5.6 | 10.3 | 5.6 | 5.2 | 7 | 0 | -16.6 | -158.6 | -210.8 | 0 | |
| Debt to Equity ⓘ | 0 | 0 | 0.4 | 0.7 | 0.7 | 0.4 | 0.3 | 0.5 | 0.3 | 0.4 | - | |
| Working Cap Days ⓘ | 83 | 90 | 189 | 332 | 270 | 290 | 287 | 351 | 6,408 | 21,738 | 0 | |
| Cash Conv. Cycle ⓘ | -82 | -119 | -17 | 95 | 52 | 59 | 153 | 249 | 3,977 | 10,012 | 0 | |
Return on Equity has increased versus last 3 years average to 1.00%
Sales growth has been subdued in last 3 years -76.76%
Net Profit has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at -75.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 0.1 | - |
| TTM Sales (₹ Cr.) | 0 | - |
| BVPS (₹.) ⓘ | 9.1 | - |
| Reserves (₹ Cr.) ⓘ | 27 | - |
| P/BV ⓘ | 0.92 | - |
| PE ⓘ | 98.12 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 6.51 / 14.41 |
| All Time Low / High (₹) | 0.08 / 56.15 |
| Market Cap (₹ Cr.) | 31.4 |
| Equity (₹ Cr.) | 7.5 |
| Face Value (₹) | 2 |
| Industry PE ⓘ | 36.2 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.
The Company was in process of setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
Vista, the largest division of Torrent Pharmaceuticals Ltd, offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd.
Download APP
